Cilostazol-imprinted polymer film-coated electrode as an electrochemical chemosensor for selective determination of cilostazol and its active primary metabolite-Reference-Cited by-同舟云学术

Cilostazol-imprinted polymer film-coated electrode as an electrochemical chemosensor for selective determination of cilostazol and its active primary metabolite

Published:2022 Issue: Volume: Page:
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Jyoti ¹,Rybakiewicz-Sekita Renata²³,Żołek Teresa⁴,Maciejewska Dorota⁴,Gilant Edyta⁵,Buś-Kwaśnik Katarzyna⁵,Kutner Andrzej⁶,Noworyta Krzysztof R.¹^ORCID,Kutner Wlodzimierz¹²^ORCID

Affiliation:

1. Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland

2. Faculty of Mathematics and Natural Sciences, School of Sciences, Institute of Chemical Sciences, Cardinal Stefan Wyszynski University in Warsaw, Wóycickiego 1/3, 01-815 Warsaw, Poland

3. Laboratory of Organic Electronics, Linköping University, Bredgatan 33, 602 21 Norrköping, Sweden

4. Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097, Warsaw, Poland

5. Łukasiewicz Research Network – Industrial Chemistry Institute, Rydygiera 8, 01-793, Warsaw, Poland

6. Department of Bioanalysis and Drug Analysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland

Abstract

An electrochemical chemosensor for cilostazol (CIL) determination was devised, engineered, and tested.

Funder

Narodowe Centrum Nauki

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2022/TB/D1TB02186A

Reference40 articles.

1. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes

2. Update on peripheral artery disease: Epidemiology and evidence-based facts

3. Effect of Cilostazol in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty